BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 12, 2008
View Archived Issues
Stanford University identifies two potential drug targets to treat malaria
Read More
Transcutaneous immunization effective in protecting against enterohemorrhagic E. coli infection
Read More
New antiinfective agents described in recent GSK patents
Read More
Activation of the unfolded protein response central in the pathogenesis of Charcot-Marie-Tooth 1B
Read More
Trophos receives grant to evaluate TRO-19622 in Parkinson's disease
Read More
Cogentus appoints Scientific Steering Committee for CGT-2168 phase III clinical program
Read More
University of Adelaide awarded AUD 2 million grant for five-year hepatitis C project
Read More
Toyama Chemical initiates phase II trial of T-5224 for rheumatoid arthritis
Read More
Takeda profiles Q3 developments
Read More
Risperidone long-acting injection delays relapse in bipolar disorder
Read More
Studies show aripiprazole efficacy in pediatric psychological disorders
Read More
Recent patents impart novel therapeutic agents for respiratory disorders
Read More
New antiinfective agents reported in recent patents
Read More
OctoPlus and Biolex commence phase IIa Locteron study in hepatitis C
Read More
MGCD-0103 receives orphan drug designation for acute myelogenous leukemia
Read More
Merck KGaA and Novo Nordisk disclose new diabetes compounds in recent patent literature
Read More
Pharmacopeia selects novel chemokine receptor antagonist for development
Read More
TopoTarget clarifies collaboration with Leo Pharma
Read More
Sosei commences AD-923 phase III studies in Europe
Read More
Promising interim results reported from phase III Zadaxin trial in hepatitis C
Read More
Symbollon Pharmaceuticals completes phase III trial of IoGen for fibrocystic breast disease
Read More
Solstice Neurosciences responds to FDA early communication regarding Myobloc for cervical dystonia
Read More
